Sugar coated tablet, 25mg/50mg. The recommended initial dose is 50mg once daily; For patients with moderate or severe hepatic insufficiency, the recommended initial dose is 25mg once a day, taken before meals (1 hour before or 2 hours after meals).
Thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura, patients with poor response to corticosteroids, immunoglobulin, or splenectomy.
REVOLADE should only be used in patients with ITP whose degree of thrombocytopenia and clinical conditions increase the risk of bleeding. REVOLADE should not be used to normalize normal platelet counts. Eltrombopag is promising for treating aplastic anemia
![5-(2-ethoxy)-phenyl-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidine-7-one](https://cimg.cphi.cn/img_Cphi_cn/Products/2025/05/29/16_54_19mhdnos0xum.png)
